/ Research

Dissecting the mechanism of cytokine release induced by T-cell engagers highlights the contribution of neutrophils

T cell engagers represent a novel promising class of cancer-immunotherapies redirecting T cells to tumor cells and have some promising outcomes in the clinic. These molecules can be associated with a mode-of-action related risk of cytokine release syndrome (CRS) in patients. Read more